Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mousa J Alhaddad"'
Autor:
Fadhel A. Alomar, Marai N. Alshakhs, Salah Abohelaika, Hassan M. Almarzouk, Mohammed Almualim, Amein K. Al-Ali, Fahad Al-Muhanna, Mohammed F. Alomar, Mousa J. Alhaddad, Mohammed S. Almulaify, Faisal S. Alessa, Ahmed S. Alsalman, Ahmed Alaswad, Sean R. Bidasee, Hassan A. Alsaad, Rudaynah A. Alali, Mona H. AlSheikh, Mohammed S. Akhtar, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Hussain Alturaifi, Keshore R. Bidasee
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-22 (2022)
Abstract Biomarkers to identify ICU COVID-19 patients at high risk for mortality are urgently needed for therapeutic care and management. Here we found plasma levels of the glycolysis byproduct methylglyoxal (MG) were 4.4-fold higher in ICU patients
Externí odkaz:
https://doaj.org/article/160b31298c434f488591bba1087f9484
Publikováno v:
Cureus.
Autor:
Ali Alsaeed, Abdullah Alkhalaf, Ali Alomran, Walaa Alsfyani, Fadhel Alhaddad, Mousa J Alhaddad
Publikováno v:
Cureus.
Autor:
Mousa J Alhaddad, Ali Alsaeed, Ridha H Alkhalifah, Makarem A Alkhalaf, Mohammed Y Altriki, Arif A Almousa, Mohammed J Alqassim, Fatimah Alibrahim
Publikováno v:
Cureus.
Autor:
Mahdi E Aljaroudi, Murtaga Makki, Mohammed Almulaify, Abdullah Alshabib, Hind Alfaddagh, Hassan Alzahrani, Sulaiman Alghamdi, Wael Alsualiman, Jaafar Alsalman, Mousa J Alhaddad
Publikováno v:
Cureus.
Autor:
Mousa J Alhaddad, Mohammed S Almulaify, Abdullah A Alshabib, Albatool A Alwesaibi, Mohammed A Alkhameys, Zainab K Alsenan, Hawra J Alsheef, Mohammed A Alsaghirat, Mohammed S Almomtan, Marai N Alshakhs
Publikováno v:
Cureus. 14(3)
Angiotensin-converting enzyme 2 (ACE2) receptor serves as a receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, to enter the lungs. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin re
Autor:
Welaia A Alsaffar, Albatool A Alwesaibi, Mousa J Alhaddad, Zainab K Alsenan, Hawra J Alsheef, Saleh H Alramadan, Hassan A Aljassas, Mohammed A Alsaghirat, Hassan J Alzahrani
Publikováno v:
Cureus
Background With the rapid spread of coronavirus disease 2019 (COVID-19), most countries took extreme measures to control the disease. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. The Ministry of Health
Autor:
Fadhel A. Alomar, Marai N. Alshakhs, Salah Abohelaika, Hassan M. Almarzouk, Mohammed Almualim, Amein K. Al-Ali, Fahad Al-Muhanna, Mohammed F. Alomar, Mousa J. Alhaddad, Mohammed S. Almulaify, Faisal S. Alessa, Ahmed S. Alsalman, Ahmed Alaswad, Sean R. Bidasee, Hassan Alsaad, Rudaynah A Alali, Mona H. AlSheikh, Mohammed S. Akhtar, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Hussain Alturaifi, Keshore R. Bidasee
Publikováno v:
Scientific reports. 12(1)
Biomarkers to identify ICU COVID-19 patients at high risk for mortality are urgently needed for therapeutic care and management. Here we found plasma levels of the glycolysis byproduct methylglyoxal (MG) were 4.4-fold higher in ICU patients upon admi